These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9889986)

  • 1. Models of antineutrophil cytoplasmic antigen-associated systemic vasculitis and their clinical relevance.
    Weening JJ; Heeringa P; Brouwer E; Tervaert JW; Kallenberg CG
    Adv Nephrol Necker Hosp; 1998; 28():63-81. PubMed ID: 9889986
    [No Abstract]   [Full Text] [Related]  

  • 2. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
    van der Veen BS; Heeringa P
    APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils and B lymphocytes in ANCA-associated vasculitis.
    Witko-Sarsat V; Daniel S; Noël LH; Mouthon L
    APMIS Suppl; 2009 Jun; (127):27-31. PubMed ID: 19515136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of endothelial injury in systemic vasculitis.
    Harper L; Savage CO
    Adv Nephrol Necker Hosp; 1999; 29():1-15. PubMed ID: 10561734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts in pathogenesis and treatment of ANCA-associated systemic vasculitides.
    Kallenberg CG; Zhao MH
    Nephrology (Carlton); 2009 Feb; 14(1):1-2. PubMed ID: 19335840
    [No Abstract]   [Full Text] [Related]  

  • 6. Review article: Leukocyte-endothelial dysregulation in systemic small vessel vasculitis.
    Pankhurst T; Savage CO; Little MA
    Nephrology (Carlton); 2009 Feb; 14(1):3-10. PubMed ID: 19143939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ANCA-associated systemic small-vessel vasculitis.
    Jayne D
    APMIS Suppl; 2009 Jun; (127):3-9. PubMed ID: 19515133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-positive vasculitis and alpha 1-antitrypsin deficiency: could free ANCA antigens released by neutrophils mediate vasculitic lesions?
    Esnault VL
    Nephrol Dial Transplant; 1997 Feb; 12(2):249-51. PubMed ID: 9132637
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary manifestations of the Churg-Strauss syndrome and related idiopathic small vessel vasculitis syndromes.
    Alberts WM
    Curr Opin Pulm Med; 2007 Sep; 13(5):445-50. PubMed ID: 17940492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. So--what's new?
    APMIS Suppl; 2009 Jun; (127):1. PubMed ID: 19515131
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular biology and vasculitis.
    Savage CO
    APMIS Suppl; 2009 Jun; (127):37-40. PubMed ID: 19515138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
    Kallenberg CG
    Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.
    de Lind van Wijngaarden RA; van Rijn L; Hagen EC; Watts RA; Gregorini G; Tervaert JW; Mahr AD; Niles JL; de Heer E; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):237-52. PubMed ID: 18077783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis.
    Son D; Kanda H; Yamaguchi A; Kawabata K; Kawakami T; Kubo K; Higashihara M; Shimizu J; Uozaki H; Kuramochi S; Misaki Y; Takeuchi F; Yamamoto K
    J Nephrol; 2009; 22(3):417-20. PubMed ID: 19557721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA signaling: not just a matter of respiratory burst.
    Preston GA; Falk RJ
    Kidney Int; 2001 May; 59(5):1981-2. PubMed ID: 11318973
    [No Abstract]   [Full Text] [Related]  

  • 17. Review article: The role of CD4(+) T cells in ANCA-associated systemic vasculitis.
    Abdulahad WH; Stegeman CA; Kallenberg CG
    Nephrology (Carlton); 2009 Feb; 14(1):26-32. PubMed ID: 19143940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of ANCA-associated glomerulonephritis.
    Muller Kobold AC; van der Geld YM; Limburg PC; Tervaert JW; Kallenberg CG
    Nephrol Dial Transplant; 1999 Jun; 14(6):1366-75. PubMed ID: 10382995
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal involvement in ANCA-associated systemic vasculitis.
    Van der Woude FJ; Ferrario F
    J Nephrol; 1999; 12(2):105-28. PubMed ID: 10378667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.